These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Acute hepatitis associated to leflunomide in a patient with rheumatoid arthritis. Chávez-López MA; Ramírez-González A; Martínez-Guevara MA Gastroenterol Hepatol; 2007; 30(7):430. PubMed ID: 17692207 [No Abstract] [Full Text] [Related]
24. Leflunomide-associated skin ulceration. McCoy CM Ann Pharmacother; 2002 Jun; 36(6):1009-11. PubMed ID: 12022903 [TBL] [Abstract][Full Text] [Related]
25. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525 [TBL] [Abstract][Full Text] [Related]
26. Peripheral neuropathy: an unwanted effect of leflunomide? Carulli MT; Davies UM Rheumatology (Oxford); 2002 Aug; 41(8):952-3. PubMed ID: 12154221 [No Abstract] [Full Text] [Related]
27. [Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy]. Braun MG; Van Rhee R; Becker-Capeller D Z Rheumatol; 2004 Feb; 63(1):84-7. PubMed ID: 14991281 [TBL] [Abstract][Full Text] [Related]
28. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug. Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154 [TBL] [Abstract][Full Text] [Related]
29. Leflunomide can potentiate the anticoagulant effect of warfarin. Lim V; Pande I BMJ; 2002 Dec; 325(7376):1333. PubMed ID: 12468482 [No Abstract] [Full Text] [Related]
30. Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis. Laborde F; Loeuille D; Chary-Valckenaere I Arthritis Rheum; 2004 Oct; 50(10):3398. PubMed ID: 15476234 [No Abstract] [Full Text] [Related]
31. Leflunomide for the treatment of rheumatoid arthritis. Olsen NJ; Strand V; Kremer JM Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065 [TBL] [Abstract][Full Text] [Related]
32. [Lichenoid drug reaction to leflunomide]. Canonne-Courivaud D; Carpentier O; Dejobert Y; Hachulla E; Delaporte E Ann Dermatol Venereol; 2003 Apr; 130(4):435-7. PubMed ID: 12843855 [TBL] [Abstract][Full Text] [Related]
33. Summaries for patients. Combination therapy for rheumatoid arthritis. Ann Intern Med; 2002 Nov; 137(9):I42. PubMed ID: 12416973 [No Abstract] [Full Text] [Related]
34. [Experience in long-term therapy of active rheumatoid arthritis with leflunomide]. Chichasova NV; Igolkina EV; Brodetskaia KA; Imametdinova GR Ter Arkh; 2005; 77(5):33-8. PubMed ID: 15989000 [TBL] [Abstract][Full Text] [Related]
35. Leflunomide, a new disease-modifying anti-rheumatic drug and the never ending rheumatoid arthritis story. Smolen JS; Graninger WB; Emery P Rheumatology (Oxford); 2000 Jul; 39(7):689-92. PubMed ID: 10908683 [No Abstract] [Full Text] [Related]
36. [Leflunomide for active rheumatoid arthritis]. Andresen PN; Hansen G; Hørslev-Petersen K Ugeskr Laeger; 2000 Sep; 162(39):5228-32. PubMed ID: 11043056 [TBL] [Abstract][Full Text] [Related]
37. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis. Alldred A; Emery P Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574 [TBL] [Abstract][Full Text] [Related]
38. Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide. Gottenberg JE; Venancie PY; Mariette X J Rheumatol; 2002 Aug; 29(8):1806-7. PubMed ID: 12180755 [No Abstract] [Full Text] [Related]
39. [Application of leflunomide in the treatment of patients with rheumatoid arthritis]. Kucharz EJ Pol Arch Med Wewn; 2001 Feb; 105(2):177-82. PubMed ID: 11505754 [No Abstract] [Full Text] [Related]
40. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Larsen A; Kvien TK; Schattenkirchner M; Rau R; Scott DL; Smolen JS; Rozman B; Westhovens R; Tikly M; Oed C; Rosenburg R; Scand J Rheumatol; 2001; 30(3):135-42. PubMed ID: 11469522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]